Skip to main content
SpringerLink
Log in

Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

This report describes the actions of the non-peptide ergot alkaloids methysergide, methylergometrine and ergometrine at two types of 5-HT receptor mediating vascular contraction; the well established 5-HT2 receptor in rabbit aorta and a non-5-HT2 receptor in rabbit saphenous vein which resembles the 5-HT1-like receptor in dog saphenous vein.

In the rabbit aorta ergometrine (1 μmol/l) and methylergometrine (0.3 μmol/l), but not methysergide, produced small contractions (14% and 7% respectively of the maximal response to 5-HT). This contraction was not related to activation of 5-HT2 receptors since it was resistant to blockade by ketanserin (0.3 μmol/l). When examined as antagonists of 5-HT-induced contractions of rabbit aorta, each ergot displayed nanomolar affinity at the 5-HT2 receptor but only methysergide behaved as a simple competitive antagonist (pKB = 8.25). Methylergometrine and ergometrine produced surmountable blockade which was accompanied by a non-parallel displacement of the 5-HT concentration-effect curves. The selective 5-HT1-like receptor agonist GR43175 (≤ 30 μmol/l) was devoid of affinity at the 5-HT2 receptor in rabbit aorta.

In the rabbit saphenous vein each of the ergots produced concentration-dependent contractions which resulted in overtly biphasic concentration-effect curves. Only the first phase of contraction mimicked the effects of 5-HT and GR43175 since contractions were not blocked by MDL 72222 (1 μmol/l), but were surmountably antagonised by methiothepin (10 nmol/1), ketanserin (0.3 μmol/l) and spiperone (0.3 μmol/l). These results are expected for interactions at the 5-HT1-like receptor in this preparation (Martin and MacLennan 1990). The mechanism(s) underlying the second phase of contraction with the ergots remains to be established. Receptor inactivation studies using the alkylating agent benextramine tetrahydrochloride enabled each agonists' affinity and efficacy at the 5-HT1-like receptor to be estimated. Affinity estimates (pKA) decreased in the order: methylergo metrine (7.79), ergometrine (7.75), 5-HT (7.19), methysergide (6.76), GR43175 (6.20), whereas efficacies (τ) decreased in the order: 5-HT (3.28), methylergometrine (2.24), GR43175 (2.14), ergometrine (1.94), methysergide (0.99). Of particular interest, methysergide was significantly lower in affinity and efficacy than its primary demethylated metabolite methylergometrine. Evidently, at the 5-HT1-like receptor mediating vascular contraction the ergots ergometrine and methylergometrine are both higher in affinity than, and comparable in efficacy to, the natural receptor agonist 5-HT. This contrasts with their actions at the 5-HT2 receptor in rabbit aorta where they demonstrated a higher affinity but much lower intrinsic efficacy than 5-HT. These results favour the view that vascular contraction induced by these ergots is more likely to be mediated by 5-HT1-like, rather than 5-HT2 receptors. These results are discussed in relation to the therapeutic applications of these ergots, particularly in obstetrics and in migraine, and to their utility as diagnostic agents in patients with Prinzmetal's variant form of angina.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Angus JA (1989) 5-HT receptors in the coronary circulation. Trends Pharmacol Sci 10:89–90

    Google Scholar 

  • Apperley E, Humphrey PPA, Levy GP (1976) Receptors for 5-HT and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol 58:211–221

    Google Scholar 

  • Apperley E, Feniuk W, Humphrey PPA, Levy GP (1980) Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol 68:215–224

    Google Scholar 

  • Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Deforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM (1982) Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 65(7):1299–1306

    Google Scholar 

  • Bianchine JR, Eade NR (1969) Vasoactive substances and fibrosis. Res Clin Stud Headache 2:60–85

    Google Scholar 

  • Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B 220:141–162

    Google Scholar 

  • Black JW, Leff P, Shankley NP, Wood J (1985) An operational model of agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol 84:561–571

    Google Scholar 

  • Brazenor RM, Angus JA (1981) Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha receptors. J Pharmacol Exp Ther 218:530–536

    Google Scholar 

  • Bredberg U, Eyjolfsdottir GS, Paalzow L, Tfelt-Hansen P, Tfelt-Hansen V (1986) Pharmacokinetics of methysergide and its metabolite methylergometrine in man. Eur J Clin Pharmacol 30:75–77

    Google Scholar 

  • Cambridge D, Whiting MV (1989) Characterising the 5-HT receptor mediating coronary vasodilatation in the dog using tryptamine analogues. Br J Pharmacol 98:750P

    Google Scholar 

  • Carroll PR, Ebeling PW, Glover WE (1974) The responses of the human temporal artery and rabbit ear artery to 5-hydroxytryptamine and some of its antagonists. Aust J Biol Sci 52:813–823

    Google Scholar 

  • Caterina R De, Carpeggiani C, L Abbate A (1984) A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal s angina. Circulation 69(5):889–894

    Google Scholar 

  • Chierchia A, Davies G, Berkenboom G, Crea F, Crean P, Maseri A (1984) α-Adrenergic receptors and coronary spasm: an elusive link. Circulation 69(1):8–14

    Google Scholar 

  • Clancy BM, Maayani S (1985) 5-Hydroxytryptamine receptor in isolated rabbit aorta: characterisation with tryptamine analogs. J Pharmacol Exp Ther 233:761–769

    Google Scholar 

  • Cohen RA (1986) Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade. J Pharmacol Exp Ther 237:548–552

    Google Scholar 

  • Connor HE, Feniuk W (1989) Influence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar artery. Br J Pharmacol 96:170–178

    Google Scholar 

  • Connor HE, Feniuk W, Humphrey PPA (1989) 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol 161:91–94

    Google Scholar 

  • Curry RS, Pepine CJ, Sabom MB, Conti CR (1979) Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation 59(2):307–312

    Google Scholar 

  • Dallas FAA, Dixon CM, McCulloch RJ, Saynor DA (1989) The kinetics of 14C-GR43175 in rat and dog. Cephalagia 9 (Suppl 9):54–56

    Google Scholar 

  • Daly CJ, McGrath JC, Wilson VG (1988) An attempt at selective protection from phenoxybenzamine of postjunctional α-adrenoceptor sybtypes mediating contractions to noradrenaline in the rabbit saphenous vein. Br J Pharmacol 95:501–511

    Google Scholar 

  • Doenicke A, Brand J, Perrin VL (1988) Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1:1309–1311

    Google Scholar 

  • Feniuk W, Humphrey PPA, Perren MJ, Watts AD (1985) A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol 86:697–704

    Google Scholar 

  • eniuk W, Humphrey PPA, Perren MJ (1989) GR43175 does not share the complex pharmacology of the ergots. Cephalagia 9 (Suppl 9):35–39

    Google Scholar 

  • Forster C, Whalley ET (1982) Analysis of the 5-hydroxytryptamine induced contraction of the human basilar arterial strip compared with the rat aortic strip in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 319:12–17

    Google Scholar 

  • Fozard JR, Gray JA (1989) 5-HT1C receptor activation: a key step in the initiation of migraine? Trends Pharmacol Sci 10:307–309

    Google Scholar 

  • Fozard JR, Mwaluko GMP (1976) Mechanism of the indirect sympathetic effect of 5-hydroxytryptamine on the isolated heart of the rabbit. Br J Pharmacol 57:115–125

    Google Scholar 

  • Freedman SB, Chierchia S, Rodriguez-Plaza L, Bugiardini R, Smith G, Maseri A (1984) Ergonovine-induced myocardial ischemia: no role for sertonergic receptors? Circulation 70(2):178–183

    Google Scholar 

  • Frenken M, Kaumann AJ (1985) Ketanserin causes surmountable antagonism of 5-hydroxytryptamine contractions of large coronary arteries of dog. Naunyn-Schmiedeberg's Arch Pharmacol 328:301–303

    Google Scholar 

  • Furchgott RF (1966) The use of \-haloalkylamines in the differentiation of receptors and determination of dissociation constants of receptor-agonist complexes. Adv Drug Res 3:21–55

    Google Scholar 

  • Glover V, Sandler M (1989) Can the vascular and neurogenic theories of migraine finally be reconciled? Trends Pharmacol Sci 10:1–3

    Google Scholar 

  • Gunning SJ, Bunce KT, Humphrey PPA (1988) Methysergide contracts guinea-pig ileum via histamine H1 receptors. Br J Pharmacol 93:238P

  • Heupler FA, Proudfit WL, Razavi M, Shirey EK, Greenstreet R, Sheldon WC (1978) Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol 41(4):631–640

    Google Scholar 

  • Heyck H (1969) Pathogenesis of migraine. Res Clin Stud Headache 2:1–28

    Google Scholar 

  • Hollingsworth M, Dascombe MJ, Price D, Acton L (1989) Ergometrine and 5-hydroxytryptamine binding sites in rat brain and myometrium. J Pharm Pharmacol 41:637–638

    Google Scholar 

  • Holtz J, Held W, Sommer O, Kühne G, Bassenge E (1982) Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs: α-adrenoceptors are not involved. Bas Res Cardiol 77:278–291

    Google Scholar 

  • Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8:59–81

    Google Scholar 

  • Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13–23

    Google Scholar 

  • Humphrey PPA, Feniuk W, Perren MJ, Connor HE, Oxford AW, Coates IH, Butina D (1988) GR43175, a selective agonist for the 5-HT1-like receptor in dog saphenous vein. Br J Pharmacol 94:1123–1132

    Google Scholar 

  • Innes IR (1962) An action of 5-hydroxytryptamine on adrenaline receptors. Br J Pharmac Chemother 19:427–441

    Google Scholar 

  • Kimball RW, Freedman AP, Vallejo E (1960) Effect of serotonin in migraine patients. Neurology 10:107–111

    Google Scholar 

  • Lance JW (1973) In: Lance JW (ed) Mechanism and management of headache, 2nd edition. Butterworth, London, pp 148–150

    Google Scholar 

  • Leff P, Martin GR (1986) Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists? Br J Pharmacol 88:585–593

    Google Scholar 

  • Leff P, Martin GR (1988) Differences in agonist dissociation constant estimates for 5-HT at 5-HT2 receptors: a problem of acute desensitisation? Br J Pharmacol 95:569–577

    Google Scholar 

  • Leff P, Martin GR, Morse JM (1986) The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues. Br J Pharmacol 89:493–499

    Google Scholar 

  • Lennox WG (1938) Ergonovine versus ergotamine as a terminator of migraine headaches. Am J Med Sci 195:458–468

    Google Scholar 

  • MacLennan SJ, Martin GR, Leff P (1988) Ergometrine: a potent agonist at 5-HT1- but not 5-HT2-receptors. Br J Pharmacol 95:574P

    Google Scholar 

  • Markowitz S, Saito K, Moskowitz MA (1988) Neurogenically mediated plasma extravasation in dura mater: Effect of ergot alkaloids. Cephalagia 8:83–91

    Google Scholar 

  • Martin GR, MacLennan SJ (1990) Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification. Naunyn-Schmiedeberg's Arch Pharmacol 342:111–119

    Google Scholar 

  • Maseri A, Pesola A, Marzilli M, Serveri S, Parodi O, L'Abbate A, Ballestra AM, Maltinti G, De Nes DM, Biagini A (1977) Coronary vasospasm in angina pectoris. Lancet 1:713–717

    Google Scholar 

  • Moir JC (1964) The obstetrician bids, and the uterus contracts. Br Med J 2:1025–1029

    Google Scholar 

  • Müller-Schweinitzer E (1980) The mechanism of ergometrine-induced coronary arterial spasm: In vitro studies on canine arteries. J Cardiovasc Pharmacol 2:645–655

    Google Scholar 

  • Müller-Schweinitzer E (1983) Vascular effects of ergot alkaloids: a study of human basilar arteries. Gen Pharmacol 14:95–102

    Google Scholar 

  • Müller-Schweinitzer E, Tapparelli C (1986) Methylergometrine, an active metabolite of methysergide. Cephalagia 6:35–41

    Google Scholar 

  • Müller-Schweinitzer E, Weidmann H (1978) Basic pharmacological properties. In: Berde B, Schild HO (eds) Ergot alkaloids and related compounds. Springer, Berlin Heidelberg New York, pp 87–232

    Google Scholar 

  • Perren MJ, Feniuk W, Humphrey PPA (1989) The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalagia 9 (Suppl 9):41–46

    Google Scholar 

  • Prinzmetal M, Kannamer R, Merliss R, Wada T, Bor N (1959) Angina pectoris 1. A variant form of angina pectoris. Preliminary report. Am J Med 27:375–388

    Google Scholar 

  • Saito K, Markowitz S, Moskowitz MA (1988) Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol 24:732–737

    Google Scholar 

  • Sakanashi M, Yonemura K (1980) On the mode of action of ergometrine in the isolated dog coronary artery. Eur J Pharmacol 64:157–160

    Google Scholar 

  • Saxena PR (1978) Arteriovenous shunting and migraine. Res Clin Stud Headache 6:89–102

    Google Scholar 

  • Saxena PR (1987) Arteriovenous anastomoses and veins in migraine research. In: Blau JN (ed) Migraine. Clinical, therapeutic, conceptual and research aspects. Chapman and Hall, London, pp 581–596

    Google Scholar 

  • Saxena PR, Verdouw PD (1984) Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br J Pharmacol 82:817–826

    Google Scholar 

  • Schoeffter P, Hoyer D (1989) How selective is GR43175? Interactions with functional 5-HTIA, 5-HTlB, 5-HTIC and 5-HTID receptors. Naunyn-Schmiedeberg's Arch Pharmacol 340:135–138

    Google Scholar 

  • Stollack JS, Furchgott RF (1983) Use of selective antagonists for determining the types of receptors mediating the action of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta. J Pharmacol Exp Ther 224:215–221

    Google Scholar 

  • Suzuki A, Higashino H, Kondo S, Yoshimura Y, Yamanishi H, Niwa A (1985) Spare receptors in the blood vessels from rats. Jpn J Pharmacol 9:271P

    Google Scholar 

  • Tapparelli C, Hof RP, Müller-Schweinitzer E (1985) Pharmacologie des derives de l'ergot de seigle utilises dans la migraine. In: Meyer P, Albin H, Jaillon P, Lhoste F (eds) Les Antimigraineux. Masson, Paris, pp 178–187

    Google Scholar 

  • Tfelt-Hansen P, Jansen I, Edvinsson L (1987) Methylergometrine antagonises 5-HT in the temporal artery. Eur J Clin Pharmacol 33:77–79

    Google Scholar 

  • Toda N, Hayashi S, Fu WLH, Nagasaka Y (1976) Serotonin antagonism in isolated canine cerebral arteries. Jpn J Pharmacol 26:57–63

    Google Scholar 

  • Trist DG Leff P (1985) Quantification of H2-agonism by clonidine and dimaprit in an adenylate cyclase assay. Agents Actions 16:222–226

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Analytical Pharmacology Group, Biochemical Sciences, Wellcome Research Laboratories, BR3 3BS, Beckenham, Kent, UK

    S. J. MacLennan & G. R. Martin

Authors
  1. S. J. MacLennan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. R. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Send offprint requests to S. J. MacLennan at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacLennan, S.J., Martin, G.R. Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction. Naunyn-Schmiedeberg's Arch Pharmacol 342, 120–129 (1990). https://doi.org/10.1007/BF00166953

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00166953

Key words

Search

Navigation